📰 Biodelivery Sciences News
Page 3 - Biodelivery Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Biodelivery Sciences. Real-time updates on events, politics, business and more.
February 14, 2022
Collegium Pharmaceutical Inc (NASDAQ:COLL) will acquire BioDelivery Sciences International Inc (NASDAQ:BDSI) at $5.60 per share in ...
February 14, 2022
Markets opened lower on Monday morning, but nothing held these two companies back.
January 31, 2022
Dr. Reddy's (RDY) earnings and revenues increase year over year in third-quarter fiscal 2022.
January 25, 2022
Shares of the small pharmaceutical company, which focuses on pain management, have been rising since it released updated guidance late last week.
January 8, 2022
9 Meters Biopharma Appoints Sarah Liu as Chief Commercial Officer and Al Medwar as Senior Vice President of Investor Relations & Corporate Communications - read this article along with other careers information, tips and advice on BioSpace
December 21, 2021
For the readers interested in the stock health of BioDelivery Sciences International Inc. (BDSI). It is currently valued at $3.30. When the transactions were called off in the previous session, Stock hit the highs of $3.3565, after setting-off with the price of $2.65. Company’s stock value dipped
November 26, 2021
Plasma Therapeutics Market May See Big Move | Baxter, Octapharma, Antares Pharma
November 25, 2021
Plasma Therapeutics Market May See Big Move | Baxter, Octapharma, Antares Pharma
November 3, 2021
BDSI earnings call for the period ending October 31, 2021.
October 21, 2021
RALEIGH - BioDelivery Sciences International (Nasdaq: BDSI) has appointed John Golubieski as the company's chief financial officer. Golubieski will begin the